Haizhi Tech GP (02706) surged over 9%, rising 9.47% to HK$31.08 as of press time, with a turnover of HK$45.0525 million.
On the news front, Haizhi Tech GP announced that the company recently entered into a strategic cooperation framework agreement with Jointown. Under the strategic cooperation framework agreement, the company and Jointown will carry out strategic cooperation around the digital and intelligent transformation of the pharmaceutical distribution industry, including but not limited to using the Atlas Graph Solution and Atlas Agent as carriers. The strategic cooperation proposed under the strategic cooperation framework agreement will achieve resource complementarity and collaborative development, facilitating the digital and intelligent transformation (i.e., AI-driven upgrade) of the pharmaceutical distribution industry.
It is also worth noting that Huatai Securities recently updated its Hang Seng Tech Index inclusion forecast, and Haizhi Tech GP remains on the predicted inclusion list. The company, driven by its Atlas Agent revenue which has caused core revenue to surge, has laid the foundation for long-term development and is expected to become one of the rebalancing candidates in this round of adjustment.
According to Haizhi Tech GP's interim results report, the company's core growth engine, the Atlas Agent business, generated revenue of RMB 115 million, a year-on-year surge of 135.6%, forming a "dual-wheel drive" development pattern together with the traditional Atlas Graph business. This validates the long-term prosperity of the "Graph + Controllable AI" industry roadmap and provides a development foundation within the growth group.
Comments